Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Anticancer agent 69

SKU: orb1688136

Description

Anticancer agent 69 (Compound 34) is a potent and selective small molecule inhibitor of the PC3 prostate cancer cell line, demonstrating an IC50 of 26 nM. Its mechanism involves elevating reactive oxygen species (ROS) and suppressing EGFR signaling, leading to apoptotic cell death. This compound is a valuable tool for investigating targeted apoptosis pathways in prostate cancer research, both in vitro and in vivo.

Research Area

Cardiovascular Research, Cell Biology, Immunology & Inflammation, Metabolism Research, Signal Transduction

Images & Validation

Key Properties

MW398.53
FormulaC19H26N8S
TargetOthers,Reactive Oxygen Species,EGFR,Apoptosis

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • DC41 [orb1709916]

    1354787-69-1

    680.22

    C37H34ClN5O4S

    50 mg, 100 mg, 25 mg
  • Anticancer agent 49 [orb1687441]

    2395009-34-2

    443.49

    C26H25N3O4

    50 mg, 100 mg, 25 mg
  • N6,N6-Dimethyl-4'-thio-adenosine [orb1908413]

    25795-69-1

    311.36

    C12H17N5O3S

    5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 500 mg
  • Bruceoside B [orb2893568]

    99.84% (May vary between batches)

    69687-69-0

    682.67

    C32H42O16

    100 mg, 25 mg, 1 mg, 10 mg, 5 mg, 50 mg
  • 2E-3-F16 [orb3133200]

    3002962-69-5

    649.66

    C39H41BrN2O2

    50 mg, 10 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information